文献速递艾滋病与性传播感染

REPRIEVE队列中HIV感染者的冠状动脉周围脂肪组织密度、炎症与亚临床冠状动脉疾病

Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.
PubMed 文献 · Clin Infect Dis · 2023-01-01

在REPRIEVE机制子研究727名HIV感染者基线分析中,冠状动脉周围脂肪组织密度与冠状动脉斑块、非钙化斑块、冠状动脉钙化>0、易损斑块及高CAD负荷(Leaman评分>5)独立相关;其密度高于匹配的Framingham心脏研究对照。

要点

  • PCAT密度与HIV感染者冠状动脉斑块患病独立相关(每10 HU调整OR 1.44,95%CI 1.22-1.70,P<.001)。
  • PCAT密度与CAC>0、非钙化斑块、易损斑块及Leaman评分>5相关(所有P≤.002)。
  • REPRIEVE参与者PCAT密度高于Framingham对照(-88.2±0.5 HU vs -90.6±0.4 HU,P<.001)。

核心结论

  • 在REPRIEVE这一大型心血管疾病一级预防队列的HIV感染者中,冠状动脉周围脂肪组织密度升高与冠状动脉斑块的患病率和严重程度独立相关,将冠状动脉炎症增加与HIV感染者的CAD联系起来。

研究设计与样本

  • REPRIEVE机制子研究的基线分析,纳入727名参与者,采用多变量逻辑回归分析CT衍生的PCAT密度与CAD存在及范围(Leaman评分)、非钙化斑块、冠状动脉钙化及易损斑块特征的关系。
  • 进一步将HIV感染者的PCAT密度与来自社区Framingham心脏研究的年龄、性别、体重指数、CAC评分和他汀使用匹配的对照(N=464)进行比较,并调整相关临床协变量。

主要发现

  • 在727名REPRIEVE参与者(年龄50.8±5.8岁;83.6%[608/727]男性)中,有冠状动脉斑块、非钙化斑块、CAC>0、易损斑块及高CAD负荷(Leaman评分>5)者的PCAT密度均高于无上述特征者(每项比较P<.001)。
  • PCAT密度与现患冠状动脉斑块相关(每10 HU调整OR 1.44;95%CI 1.22-1.70;P<.001),已调整临床心血管危险因素、体重指数和系统性免疫/炎症生物标志物。
  • PCAT密度同样与CAC>0、非钙化斑块、易损斑块及Leaman评分>5相关(所有P≤.002)。
  • REPRIEVE参与者的PCAT密度高于Framingham心脏研究对照(-88.2±0.5 HU vs -90.6±0.4 HU;P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pericoronary adipose tissue (PCAT) may influence plaque development through inflammatory mechanisms. We assessed PCAT density, as a measure of pericoronary inflammation, in relationship to coronary plaque among people with human immunodeficiency virus (HIV [PWH]) and to a matched control population. METHODS: In this baseline analysis of 727 participants of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) Mechanistic Substudy, we related computed tomography-derived PCAT density to presence and extent (Leaman score) of coronary artery disease (CAD), noncalcified plaque, coronary artery calcium (CAC), and vulnerable plaque features using multivariable logistic regression analyses. We further compared the PCAT density between PWH and age, sex, body mass index, CAC score, and statin use-matched controls from the community-based Framingham Heart Study (N = 464), adjusting for relevant clinical covariates. RESULTS: Among 727 REPRIEVE participants (age 50.8 ± 5.8 years; 83.6% [608/727] male), PCAT density was higher in those with (vs without) coronary plaque, noncalcified plaque, CAC >0, vulnerable plaque, and high CAD burden (Leaman score >5) (P < .001 for each comparison). PCAT density related to prevalent coronary plaque (adjusted odds ratio [per 10 HU]: 1.44; 95% confidence interval, 1.22-1.70; P < .001), adjusted for clinical cardiovascular risk factors, body mass index, and systemic immune/inflammatory biomarkers. Similarly, PCAT density related to CAC >0, noncalcified plaque, vulnerable plaque, and Leaman score >5 (all P ≤ .002). PCAT density was greater among REPRIEVE participants versus Framingham Heart Study (-88.2 ± 0.5 HU versus -90.6 ± 0.4 HU; P < .001). CONCLUSIONS: Among PWH in REPRIEVE, a large primary cardiovascular disease prevention cohort, increased PCAT density independently associated with prevalence and severity of coronary plaque, linking increased coronary inflammation to CAD in PWH.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Foldyna B, Mayrhofer T, Zanni MV, et al. Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort. Clin Infect Dis. 2023. PMID: 37439633. doi:10.1093/cid/ciad419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。